FRLN

$6.48+$0.00 (+0.00%)prev close

Compare

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Change$-43.77

Earnings surprises

Beat consensus in 5 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2024-04-02	$-0.26	$-5.22	-1907.7%
2023-12-01	$-0.23	$-0.18	+21.7%
2023-08-15	$-3.62	$-0.21	+94.2%
2023-05-30	$-1.64	$-0.29	+82.3%
2023-03-30	$-0.29	$-0.97	-234.5%
2022-11-15	$-6.42	$-2.99	+53.4%
2022-08-09	$-8.06	$-4.78	+40.7%
2022-05-10	$-8.66	$-9.40	-8.5%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
FRLNFreeline Therapeutics Holdings plc	$6.49	+0.15%	$28M	—
ALLKAllakos Inc.	$0.33	+0.22%	$30M	—
ANGNAngion Biomedica Corp.	$1.00	+0.00%	$30M	—
ANPCAnPac Bio-Medical Science Co., Ltd.	$4.30	-3.15%	$27M	—
ELEVElevation Oncology, Inc.	$0.36	-2.12%

Held by traders on TradeandTell

No one on the platform currently holds FRLN.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in FRLN as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Stock splits

Execution date	Ratio
2023-05-12	1-for-15reverse

Recent trades on TradeandTell

No one on the platform has traded FRLN yet.

$FRLN chatter on StockTwits

StockTitan@Stock_TitanApr 24
$FRLN Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting https://www.stocktitan.net/news/FRLN/freeline-to-present-new-data-on-its-gaucher-and-parkinson-s-disease-y80a9tno5fg3.html
View on StockTwits ↗
El Capitan T@Stocks4thoughtFeb 25
$GANX GBA1 VALID TARGET $lly $frln (TAKEN OUT)...... $NBIX
View on StockTwits ↗
Noobbroker22@Noobbroker22Feb 21
$FRLN whats going to happen to the shares that ibown in the stock
View on StockTwits ↗
StockTitan@Stock_TitanFeb 20
$FRLN Acquisition of Freeline by Syncona Becomes Effective https://www.stocktitan.net/news/FRLN/acquisition-of-freeline-by-syncona-becomes-gxtyf1m0b3e1.html
View on StockTwits ↗
Robert C@RastroFeb 12
$FRLN Disappointing to shareholders; but congratulations to Syncona! You are acquiring a company privately which I strongly believe will help a lot of people very soon.
View on StockTwits ↗
StockTitan@Stock_TitanFeb 12
$FRLN Freeline Shareholders Approve Acquisition by Syncona https://www.stocktitan.net/news/FRLN/freeline-shareholders-approve-acquisition-by-j8m5yw0lf1c2.html
View on StockTwits ↗
CRNMNAKIBN@CRNMNAKIBNBearishDec 11
$FRLN sold
View on StockTwits ↗
Robert C@RastroDec 8
$FRLN Shame on Freeline's board for listening to and accepting the 'Siren Song' of Syncona.
View on StockTwits ↗
BINI 𝓜Δ𝕤𝐭𝒆ｒ since 2018@jpstringsDec 5
$AMBI $PTON $FRLN $LOGC @Stocktwits reported for scam spam
View on StockTwits ↗
Justin@YouVSYouBullishNov 30
@YOUvsYou $fcel $poww $frln Unpopular Ideas 💡
View on StockTwits ↗
CRNMNAKIBN@CRNMNAKIBNBullishNov 28
$GME come to $FRLN
View on StockTwits ↗
Briefing.com@briefingcomNov 22
$FRLN: Syncona to acquire Freeline Therapeutics Holdings for $6.50/share for each Freeline ADR https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20231122073409FRLN
View on StockTwits ↗
MarketBeat Earnings@EarningsInsiderNov 22
Freeline Therapeutics Holdings plc Files SEC Form 6-K $FRLN https://www.marketbeat.com/stocks/NASDAQ/FRLN/sec-filings/
View on StockTwits ↗
George@OrlandotraderNov 22
$FRLN Syncona just got a Great Deal!! Shareholders Not!!
View on StockTwits ↗
Amanda G. Beckett@Amanda0043Nov 22
$TSLA $FRLN Analyst price target for today<< top-trading-community.stocktraders.live
View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.